Rep. Neal Patrick Dunn (R-Florida) recently provided insightful testimony regarding H.R.7253 – Clarifying Remanufacturing to Protect Patient Safety Act of 2022. Dunn’s statements come from a legislator who is also a health care professional. He is a surgeon and Republican Party politician serving as the U.S. representative for Florida’s 2nd congressional district since 2017.
“H.R. 7253, as written, is problematic. I acknowledge and understand the intentions and the good intentions of Dr. Schrier and Joyce trying to define the exact difference between true servicing and remanufacturing of medical devices, but I would like to lend my experience to this conversation surrounding the issue I think there’s a lot of work to be done on HR 7253,” Dunn said during his testimony.
He goes on to talk about the importance of prompt service/repair of medical devices. He says delays can result in patient deaths.
“What I would like to do is work with the OEMs, work with the sponsors of the bill, I want to be sure that we have a clear definition of servicing,” Dunn said.
“I can’t get behind this bill,” he added.
TechNation previously reported on this bill.
“U.S. Rep. Scott A. Peters (D-California) is attempting to define “remanufacturing” when it comes to medical devices via H.R. 7253. The bill – “Clarifying Remanufacturing to Protect Patient Safety Act of 2022’’ – is co-sponsored by Rep. John Joyce (R-Pennsylvania) and Rep. Kim Schrier (D-Washington). “Remanufacturing” is a term that has befuddled healthcare technology management (HTM) professionals, original equipment manufacturers (OEMs), the FDA and other stakeholders for at least half a decade. H.R. 7253 appears to offer changes to 21 USC 360: Registration of producers of drugs or devices,” a March 31, 2022 article states.